News | January 01, 2008

Reactions to Gadolinium-Based Contrast Agents Rare

January 2, 2008 – Allergic-like reactions to gadolinium-containing contrast injections in adults and pediatric patients, under the age of 19, are rare, according to a study conducted by researchers at the University of Michigan Health Systems in Ann Arbor, MI,.
Studying 78,353 gadolinium-containing contrast injections over five years, acute allergic-like reactions occurred after 54 injections, 48 reactions involved adults and six occurred in pediatric patients. Seventy-four percent of these reactions were mild, 19 percent were moderate and seven percent were marked as severe.

"Despite recent concerns that have emerged about the gadolinium-based contrast agents and the development of nephrogenic systemic fibrosis in patients who have severe chronic kidney disease, our study supports the long-held belief that gadolinium based contrast agents can be used safely in both pediatric and adult patients with normal or with only mildly impaired renal function," said Dr. Richard Cohan, co-author of the study. "The risk of allergic-like reactions is exceedingly low (0.07 percent of administrations in our study), and no fatal reaction occurred at our institution in more than 78,000 intravenous administrations. Patients should feel reassured, based on our results, that the intravenous gadolinium-contrast agents included in our study are quite safe when administered to patients with ample renal function," he said.

For more information: http://www.arrs.org

Related Content

ACR Offers Revised Contrast Media in Imaging Manual
News | Contrast Media| July 17, 2017
The American College of Radiology (ACR) recently revised its authoritative guide for the safe and effective use of...
Osprey Avert
News | Cath Lab| May 13, 2016
May 13, 2016 — In the largest study of its kind, a new device has been found to significantly reduce the volume of ra
GlobalData, contrast media injectors market,
News | Contrast Media Injectors| May 03, 2016
The global market for contrast media injectors is set to increase from $830 million in 2015 to almost $1.8 billion by...
Galt Medical, Health Line International Corp., Nexus CT Midline Catheter with MST Insertion Kit

Image courtesy of Galt Medical

Technology | Contrast Media Injectors| October 01, 2015
Galt Medical has partnered with Health Line International Corp. and launched the Nexus CT Midline Catheter with MST...
Technology | March 06, 2015
Bracco Imaging, through its business unit Bracco Injeneering SA, announced the availability of its EmpowerCTA+, an...
Contrast media injectors. angiography contrast injectors

The Bayer Arterion contrast injector.

Feature | Contrast Media Injectors| February 10, 2015 | Raissa Rocha and Dave Fornell
There have been several recent advances with contrast media injector technology, including cutting costs by reducing...
Technology | December 23, 2014
Bayer unveiled version 2.5 of its Radimetrics Enterprise Platform at the 2014 Radiological Society of North America (...
Technology | November 24, 2014
Bracco Diagnostics Inc. announced the availability of its Isovue (iopamidol injection) Imaging Bulk Package (IBP), a...
Guerbet FlowSens Contrast Media Injectors CT Systems X-Ray
Feature | March 11, 2014
Guerbet announced a worldwide launch of FlowSens, a ...
Overlay Init